Currently a fifth of prescriptions for the drug are issued privately because the NHS has put strict limits on its use at the taxpayer's expense. Pfizer's loss of the patent will mean that the NHS, which spent £40.3m on the drug last year, will make big savings, Generic makers of the drug are expected to slash the price of a pill from £10 to as little as 85p.